...
首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis.
【24h】

Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis.

机译:在实验性自身免疫性葡萄膜炎期间,局部施用表达IL-10的腺相关病毒载体可减少单核细胞浸润和随后的感光细胞损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

Autoimmune posterior uveitis is a chronic, potentially blinding inflammatory disease of the eye. It is commonly treated with immunosuppressive drugs that have adverse long-term effects. Advances in gene transfer techniques have enabled long-term, stable transduction of retinal cells following subretinal injection with adeno-associated viral (AAV) vectors. Here we report for the first time that subretinal injection of rAAV-2 encoding murine IL-10 into the retina of C57BL/6 mice significantly decreases the median experimental autoimmune uveitis (EAU) disease severity. This protection is shown to be due to a decrease in the number and activation status of infiltrating monocytes during EAU, as determined by costimulatory molecule expression and nitrotyrosine detection. No differences within splenocyte proliferative responses or serum antibody levels were detected, emphasizing the potential of gene therapy strategies in ameliorating autoimmune responses in local microenvironments without unwanted systemic effects.
机译:自身免疫性后葡萄膜炎是一种慢性的,可能使眼睛致盲的炎性疾病。通常用具有不良长期影响的免疫抑制药治疗。基因转移技术的进步使得在视网膜下注射腺相关病毒(AAV)载体后能够长期,稳定地转导视网膜细胞。在这里,我们首次报告视网膜下注射鼠源IL-10的rAAV-2编码到C57BL / 6小鼠的视网膜中,可显着降低实验性自身免疫性葡萄膜炎(EAU)疾病的严重程度。已显示出这种保护是由于在EAU期间浸润的单核细胞数量和激活状态的减少,这是通过共刺激分子表达和硝基酪氨酸检测确定的。没有检测到脾细胞增殖反应或血清抗体水平之间的差异,强调了基因治疗策略在改善局部微环境中的自身免疫反应中的潜力,而没有不希望的全身作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号